San Francisco VA Medical Center, San Francisco, CA
San Francisco, California, 94121, United States
NCT Number: NCT00674570
This is a research study examining the use of two medications, Hydrocortisone and D-Cycloserine, compared to an inactive substance (placebo), on their ability to reduce fear responses and memory of fear in Veterans with symptoms of Posttraumatic Stress Disorder (PTSD). These responses will be tested using a fear learning and memory task administered by computer.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
San Francisco, California, 94121, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
25 mg/oral one hour prior to extinction task
50 mg/oral one hour prior to extinction task
One hour prior to extinction task
Time frame: 15 minute measurement intervals on Study Days 7, 9, and 16
Psychophysiology measurements occurred on day 7 for fear conditioning, day 9 for fear extinction, and day 11 for extinction retention. The primary outcome measures are presented for the first and last conditioned stimulus (CS) trials during fear conditioning and extinction and for the first 2 trials during retention. Conditioned Responses (CR): An SCR score was obtained for each CS by subtracting the mean skin conductance level (SCL) in microsiemens (µS) for the 2-s interval immediately preceding CS onset from the max SC level in µS during the 8-s CS presentation. Unconditioned Response (UCR): An SCR score for the UCR was obtained by subtracting the mean SCL in µS within 6-8 s following CS offset from the max increase in SC level during the .5-6.5 time interval following the CS offset, corresponding to the onset of the .5s US. SC responses were range corrected using each participant's maximum response to the UCS or CS during acquisition trials of the fear conditioning phase.
VA Office of Research and Development
Fed
Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder
Acronym: VSL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04651296
Behavior, Behavioral Symptoms
San Diego, California, United States
View Trial DetailsNCT02226367
Alcohol Use Disorders, Alcohol-Related Disorders
Tacoma, Washington, United States
View Trial DetailsNCT04002050
Anxiety Disorders, Behavior
Winnipeg, Manitoba, Canada
View Trial DetailsNCT00373698
Behavior, Behavioral Symptoms
Dallas, Texas, United States
View Trial Details